Janssen enters global collaboration with Achillion Pharmaceuticals, Inc. to fight hepatitis C virus
[ad_1] TITUSVILLE, NJ, May 19, 2015 / PRNewswire / – Janssen Pharmaceuticals, Inc. (Janssen), one of Johnson & Johnson’s Janssen pharmaceutical companies, today announced that it has entered into an exclusive worldwide license and collaboration agreement with Achillion Pharmaceuticals, Inc (Achillion) to develop and commercialize one or more of the main assets of Achillion hepatitis […]